Bioxodes is a dynamic biotech start-up specialized in the development of novel therapeutics using molecules derived from nature to prevent thrombosis and inflammatory processes

NEWS

- Bioxodes is currently looking for a Chief Medical Officer. 

- Bioxodes obtained authorization to launch phase I trial of its antithrombotic drug, Ir-CPI, in healthy male volunteers.